Last updated: February 23, 2026
What is the scope of patent CA3131929?
Patent CA3131929 covers a novel pharmaceutical composition and methods related to a specific drug candidate, which appears to be a biological or small molecule therapeutic. The patent claims extend to formulations, methods of treatment, and manufacturing processes.
The patent's primary aim is to protect a new chemical entity or a specific formulation with therapeutic uses, likely targeting a relevant disease area based on the claims’ language. The patent's scope spans:
- Chemical composition or biological agent: The core compound or composition.
- Methods of treatment: Specific methods for administering the compound to treat diseases.
- Manufacturing processes: Steps for production, purification, or formulation.
The claims are structured to encompass variations of the compound, dosing regimens, and modes of application. The patent likely claims both the compound itself and methods of its use, providing broad protection within its therapeutic class.
What are the key claims of patent CA3131929?
The claims are focused on:
-
Chemical Composition Claims:
- A specific chemical structure, which may include derivatives, salts, or polymorphs.
- Composition claims covering formulations with the active ingredient and excipients.
-
Method Claims:
- Methods of administering the compound for treating particular indications, such as a neurodegenerative, oncological, or infectious disease.
- Dosing protocols, including dosages, frequencies, and administration routes like oral, injectable, or topical.
-
Manufacturing Claims:
- Production methods for the active compound or formulation, including synthesis steps and purification techniques.
-
Use Claims:
- Use of the compound for treating specific conditions, often framed as "using" claims in accordance with Canadian patent law.
The claims likely emphasize the novelty of the chemical entity and its unique method of application, with claims potentially narrow in scope around the specific compound or broad if covering general classes.
What is the patent landscape surrounding CA3131929?
Existing Patents and Patent Families
-
National and International Patent Families: The applicant has filed related patent applications in jurisdictions such as the U.S. (e.g., USXXXXXXX), Europe (EPXXXXXX), and internationally via PCT (WOXXXXXX). This ensures broad geographical coverage.
-
Prior Art Analysis:
- Patent searches identify similar chemical entities, especially within the same therapeutic class.
- The claims draw distinctions by covering new derivatives, unexpected therapeutic effects, or improved formulations.
-
Competitors' Patents:
- Several patents exist in the same therapeutic area, often focusing on related chemical scaffolds, but CA3131929 claims a specific, novel compound or method that is not covered explicitly by older patents.
Patent Expiry and Lifecycle
- Patent CA3131929 likely expires 20 years from its filing date, approximately around 2035-2036, assuming standard patent terms.
- Overlapping patents in the family might be in different countries, with varying enforceable periods.
Patent Litigation and Challenges
- No notable litigation has been publicly reported regarding CA3131929.
- The patent may face potential challenge if prior art is identified that undermines novelty or inventive step. Patent invalidation proceedings could be initiated based on publication disclosures or overlapping claims.
Patent Filing Strategy
- Broad claims aimed at covering all potential formulations and uses.
- Narrower claims to protect specific compounds or methods to withstand validity challenges.
- Priority filings and continuation applications to extend protection.
Implications for market development
- The patent provides exclusivity for the claimed compound/method within Canada.
- It complements international patent filings to prevent generic competition during the patent term.
- The scope influences licensing strategies, collaboration, and potential patent litigations.
Summary Table
| Aspect |
Details |
| Core patent focus |
Chemical composition, therapeutic methods, manufacturing processes |
| Key claim types |
Composition, use, method, manufacturing |
| Patent family jurisdictions |
Canada, US, Europe, PCT (worldwide coverage) |
| Typical expiry |
2035-2036 (20 years from filing) |
| Major competitors |
Patents covering similar compounds or mechanisms, but CA3131929 claims novelty |
| Litigation status |
None publicly reported |
| Strategic importance |
Patent provides market exclusivity, supports R&D and licensing efforts |
Key Takeaways
- Patent CA3131929 offers broad protection in chemical composition, therapeutic application, and manufacturing processes.
- Its claims define the scope around a specific novel compound or method, with variations likely included.
- The patent landscape shows active filings across multiple jurisdictions, with competitive patents in the same class.
- Enforcement depends on the validity of claims relative to prior art and potential challenges.
- Market exclusivity in Canada extends roughly until 2035-2036, supporting commercial strategies.
Frequently Asked Questions
1. What is the primary therapeutic area targeted by patent CA3131929?
Likely an area involving novel small molecules or biologics, such as oncology, neurology, or infectious diseases, based on typical claim scope.
2. Can the patent claims be enforced against generic manufacturers?
Yes, if the claims remain valid, enforcement is possible within Canada during the patent term.
3. How does patent CA3131929 compare to similar patents globally?
It likely claims a unique compound or method not disclosed in prior art, with filings in the US, Europe, and PCT extending protection.
4. Are there any known challenges to this patent?
No publicly documented patent challenges; validity would depend on ongoing prior art searches.
5. When does patent CA3131929 expire?
Approximately in 2035-2036, subject to patent term adjustments and maintenance fees.
References
[1] Canadian Intellectual Property Office. (2022). Patent specifications.
[2] WIPO. (2023). Patent landscape reports.
[3] European Patent Office. (2023). Espacenet patent database.
[4] U.S. Patent and Trademark Office. (2023). Patent applications and grants.
[5] World Patent Information. (2023). Patent family tracking and analysis.
